Oramed Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
0.75 |
2.00 |
0.89 |
0.78 |
| Przychód Δ r/r |
0.00% |
166.67% |
-55.28% |
-12.61% |
| Przychód (min) |
0.75 |
2.00 |
0.89 |
0.78 |
| Przychód (max) |
0.75 |
2.00 |
0.89 |
0.78 |
| EBITDA (średnia) |
-0.75 |
-2.00 |
-0.89 |
-0.78 |
| EBIT (średnia) |
-0.75 |
-2.00 |
-0.89 |
-0.78 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-28.24 |
-13.79 |
-51.11 |
-33.26 |
| Zysk netto % |
-3765.07% |
-689.64% |
-5714.73% |
-4255.58% |
| EPS (średnia) |
-0.24 |
-0.34 |
-1.26 |
-0.82 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
| symbol |
ORMP |
ORMP |
ORMP |
ORMP |